Teladoc Health, Inc.
TDOC
$6.47
-$0.07-1.07%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -1.13% | -4.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.13% | -4.43% | |||
| Cost of Revenue | -3.39% | 0.24% | |||
| Gross Profit | -0.06% | -6.49% | |||
| SG&A Expenses | -2.65% | -0.28% | |||
| Depreciation & Amortization | -1.49% | -2.69% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.19% | -1.00% | |||
| Operating Income | 29.20% | -80.69% | |||
| Income Before Tax | 37.69% | -80.98% | |||
| Income Tax Expenses | -66.71% | 135.34% | |||
| Earnings from Continuing Operations | 39.05% | -153.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.05% | -153.90% | |||
| EBIT | 29.20% | -80.69% | |||
| EBITDA | 259.80% | -80.88% | |||
| EPS Basic | 39.70% | -152.05% | |||
| Normalized Basic EPS | 26.92% | -93.06% | |||
| EPS Diluted | 39.70% | -152.05% | |||
| Normalized Diluted EPS | 26.92% | -93.06% | |||
| Average Basic Shares Outstanding | 1.06% | 0.73% | |||
| Average Diluted Shares Outstanding | 1.06% | 0.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||